Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
3.230
-0.165 (-4.86%)
At close: Jun 5, 2026, 4:00 PM EDT
3.290
+0.060 (1.86%)
After-hours: Jun 5, 2026, 7:03 PM EDT
Agenus Market Cap
Agenus has a market cap or net worth of $134.17 million as of June 5, 2026. Its market cap has increased by 27.42% in one year.
Market Cap
134.17M
Enterprise Value
140.25M
1-Year Change
27.42%
Ranking
Category
Stock Price
$3.23
Market Cap Chart
Since February 8, 2000, Agenus's market cap has decreased from $1.10B to $134.17M, a decrease of -87.77%. That is a compound annual growth rate of -7.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 141.40M | 32.40% |
| Dec 31, 2025 | 106.80M | 66.10% |
| Dec 31, 2024 | 64.30M | -79.64% |
| Dec 29, 2023 | 315.80M | -56.83% |
| Dec 30, 2022 | 731.50M | -11.55% |
| Dec 31, 2021 | 827.00M | 36.76% |
| Dec 31, 2020 | 604.70M | 8.16% |
| Dec 31, 2019 | 559.10M | 95.76% |
| Dec 31, 2018 | 285.60M | -12.55% |
| Dec 29, 2017 | 326.60M | -9.03% |
| Dec 30, 2016 | 359.00M | -6.58% |
| Dec 31, 2015 | 384.30M | 54.40% |
| Dec 31, 2014 | 248.90M | 165.92% |
| Dec 31, 2013 | 93.60M | -7.14% |
| Dec 31, 2012 | 100.80M | 134.97% |
| Dec 30, 2011 | 42.90M | -57.23% |
| Dec 31, 2010 | 100.30M | 74.74% |
| Dec 31, 2009 | 57.40M | 80.50% |
| Dec 31, 2008 | 31.80M | -67.22% |
| Dec 31, 2007 | 97.00M | 15.61% |
| Dec 29, 2006 | 83.90M | -61.34% |
| Dec 30, 2005 | 217.00M | -52.90% |
| Dec 31, 2004 | 460.70M | 2.90% |
| Dec 31, 2003 | 447.70M | 32.18% |
| Dec 31, 2002 | 338.70M | -28.80% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AN2 Therapeutics | 150.10M |
| Corbus Pharmaceuticals Holdings | 148.41M |
| NRx Pharmaceuticals | 146.59M |
| Connect Biopharma Holdings | 144.82M |
| Molecular Partners AG | 144.58M |
| Spruce Biosciences | 143.68M |
| TuHURA Biosciences | 139.46M |
| Canton Strategic Holdings | 138.81M |